# Absci Corp: overview

ABSI · Nasdaq · CIK 1672688 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/absi.md) · [Financials](/companies/absi/financials.md) · [Filings](/companies/absi/filings.md) · [Insiders](/companies/absi/insiders.md)

Latest reported revenue: [$318.0k](/filings/0001672688-26-000136.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 11, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001672688-26-000136).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.7](/filings/0001628280-24-046862.md) | [0.7 d](/filings/0001628280-25-013464.md) | [1.2](/filings/0001672688-26-000088.md) | [0.6](/filings/0001672688-26-000136.md) | [0.4](/filings/0001672688-25-000084.md) | [0.7 d](/filings/0001672688-26-000068.md) | [0.2](/filings/0001672688-26-000088.md) | [0.3](/filings/0001672688-26-000136.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(1698.7%)](/filings/0001672688-25-000084.md) | [(4477.3%) d](/filings/0001672688-26-000068.md) | [(2351.9%)](/filings/0001672688-26-000088.md) | [(5293.9%)](/filings/0001672688-26-000136.md) | [(7977.2%)](/filings/0001672688-25-000084.md) | [(4775.5%) d](/filings/0001672688-26-000068.md) | [(14347.0%)](/filings/0001672688-26-000088.md) | [(10741.5%)](/filings/0001672688-26-000136.md) |
| Net margin | % | [(1610.7%)](/filings/0001672688-25-000084.md) | [(4358.3%) d](/filings/0001672688-26-000068.md) | [(2234.6%)](/filings/0001672688-26-000136.md) | [(5155.0%)](/filings/0001672688-26-000136.md) | [(7594.2%)](/filings/0001672688-25-000084.md) | [(4548.0%) d](/filings/0001672688-26-000068.md) | [(13767.0%)](/filings/0001672688-26-000136.md) | [(10443.4%)](/filings/0001672688-26-000136.md) |
| Diluted EPS | $ per share | [(0.24)](/filings/0001672688-25-000084.md) | not reported | [(0.21)](/filings/0001672688-26-000088.md) | [(0.24)](/filings/0001672688-26-000136.md) | [(0.20)](/filings/0001672688-25-000084.md) | not reported | [(0.19)](/filings/0001672688-26-000088.md) | [(0.21)](/filings/0001672688-26-000136.md) |
| Free cash flow | $m | [(20.8) d](/filings/0001672688-25-000084.md) | [(17.0) d](/filings/0001672688-26-000068.md) | [(21.9)](/filings/0001672688-26-000088.md) | [(17.1) d](/filings/0001672688-26-000136.md) | [(26.0) d](/filings/0001672688-25-000084.md) | [(29.3) d](/filings/0001672688-26-000068.md) | [(26.3)](/filings/0001672688-26-000088.md) | [(27.6) d](/filings/0001672688-26-000136.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4.8](/filings/0001628280-23-009908.md) | [5.7](/filings/0001628280-24-012366.md) | [5.7](/filings/0001628280-25-013464.md) | [4.5](/filings/0001628280-25-013464.md) | [2.8](/filings/0001672688-26-000068.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(1573.4%)](/filings/0001628280-23-009908.md) | [(1857.5%)](/filings/0001628280-24-012366.md) | [(2020.2%)](/filings/0001628280-25-013464.md) | [(2401.6%)](/filings/0001672688-26-000068.md) | [(4297.0%)](/filings/0001672688-26-000068.md) |
| Net margin | % | [(2111.3%)](/filings/0001628280-23-009908.md) | [(1825.4%)](/filings/0001628280-24-012366.md) | [(1933.6%)](/filings/0001628280-25-013464.md) | [(2274.1%)](/filings/0001672688-26-000068.md) | [(4113.7%)](/filings/0001672688-26-000068.md) |
| Diluted EPS | $ per share | [(2.08)](/filings/0001628280-23-009908.md) | [(1.15)](/filings/0001628280-24-012366.md) | [(1.20)](/filings/0001628280-25-013464.md) | [(0.94)](/filings/0001672688-26-000068.md) | [(0.84)](/filings/0001672688-26-000068.md) |
| Free cash flow | $m | [(98.6)](/filings/0001628280-23-009908.md) | [(97.5)](/filings/0001628280-24-012366.md) | [(65.5)](/filings/0001628280-25-013464.md) | [(72.8)](/filings/0001672688-26-000068.md) | [(94.0)](/filings/0001672688-26-000068.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/absi/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $294.5m | 25,410,048 |  | Added +2,859,051 |
| [ARK Investment Management LLC](/funds/1697748.md) | 2026-06-30 | $149.8m | 12,925,271 |  | Reduced −800,898 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $141.1m | 12,175,302 |  | Added +920,108 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $93.8m | 8,097,308 |  | Added +772,450 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $81.0m | 6,991,763 |  | Added +3,811,622 |
| [Redmile Group, LLC](/funds/1425738.md) | 2026-06-30 | $78.1m | 6,739,675 |  | Reduced −1,513,641 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $71.0m | 6,122,677 |  | Added +236,037 |
| [ADVANCED MICRO DEVICES INC](/funds/2488.md) | 2026-06-30 | $66.2m | 5,714,285 |  | Unchanged |
| [ADAGE CAPITAL PARTNERS GP, L.L.C.](/funds/1165408.md) | 2026-06-30 | $66.1m | 5,704,820 |  | New +5,704,820 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $63.7m | 5,493,486 |  | Added +2,594,720 |

## Recent filings

[All 356 filings](/companies/absi/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 16:08 ET | [10-Q](/filings/0001672688-26-000136.md) | Quarterly report, period 2026-06-30 | 0001672688-26-000136 |
| 2026-08-11 | 16:06 ET | [8-K](/filings/0001672688-26-000134.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001672688-26-000134 |
| 2026-06-24 | 16:31 ET | [8-K](/filings/0001193125-26-281143.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-281143 |
| 2026-06-24 | 06:32 ET | [8-K](/filings/0001672688-26-000118.md) | 8.01 Other events | 0001672688-26-000118 |
| 2026-06-05 | 16:08 ET | [8-K](/filings/0001672688-26-000095.md) | 5.07 Shareholder vote results | 0001672688-26-000095 |
| 2026-05-07 | 16:24 ET | [10-Q](/filings/0001672688-26-000088.md) | Quarterly report, period 2026-03-31 | 0001672688-26-000088 |
| 2026-05-07 | 16:21 ET | [8-K](/filings/0001672688-26-000086.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001672688-26-000086 |
| 2026-04-22 | 16:05 ET | [DEF 14A](/filings/0001672688-26-000078.md) | Proxy statement, period 2026-04-22 | 0001672688-26-000078 |
| 2026-04-14 | 21:00 ET | [SCHEDULE 13D/A](/filings/0001104659-26-043389.md) | Ownership report, active investor, amended | 0001104659-26-043389 |
| 2026-03-26 | 17:00 ET | [SCHEDULE 13D/A](/filings/0001104659-26-035269.md) | Ownership report, active investor, amended | 0001104659-26-035269 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001672688-26-000068.md), filed Mar 24, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/f269f427-9ac2-4d13-bd32-7303ed8a67a4)

## About the filer

- CIK: 1672688
- Tickers: ABSI
- Exchange: Nasdaq
- SIC code: 8731 Services-Commercial Physical & Biological Research
- State of incorporation: not reported
- Filer category: Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:29 ET. No prices; not investment advice.